Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Nanobiotix S.A. NANO.PA
$4.60
-$0.15 (-3.36%)
На 18:01, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
167697180.00000000
-
week52high
7.10
-
week52low
1.61
-
Revenue
0
-
P/E TTM
-3
-
Beta
1.78778600
-
EPS
-1.26000000
-
Last Dividend
0.00000000
-
Next Earnings Date
25 апр 2023 г. в 12:00
Описание компании
Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. Nanobiotix S.A. has a partnership with LianBio to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. The company was incorporated in 2003 and is headquartered in Paris, France.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Evercore ISI Group | Outperform | 06 янв 2021 г. |
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Свежие комментарии
Свежие комментарии